Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2022studies shown
Showing 1,476-1,500 of 2,022
CompletedNCT06718556

Virtual Reality for Visual Perception on Schizophrenia

This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Turkey
Sponsor
Saglik Bilimleri Universitesi
Condition
Schizophrenia
CompletedNCT06225115

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of KYN-5356 in Healthy Subjects Aged 18 to 55 Years

This study exists to compare options and see whether the medication KYN-5356 offers something meaningfully different. Researchers are trying to understand how people respond to the medication KYN-5356 in practice and what may need to be adjusted.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
United States
Sponsor
Kynexis B.V.
Condition
Schizophrenia
RecruitingNCT05127278

E-Detection Tool for Emerging Mental Disorders

This study exists to understand how a digital app or remote support tool holds up over time after the earliest research stage. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 12 Years to 35 Years
Countries
United Kingdom
Sponsor
King's College London
Condition
Schizophrenia
CompletedNCT03583073

Psychosis Screening in Juvenile Justice

This study exists to understand what helps a digital app or remote support tool work in everyday practice, not just under ideal conditions. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 12 Years to 17 Years
Countries
United States
Sponsor
Brown University
Condition
Schizophrenia
RecruitingNCT06703827

Effects of Online Metacognitive Training Group on Distressing Beliefs

This study exists to see whether cognitive behavioural therapy, a structured talking treatment, can play a useful role in care. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United Kingdom
Sponsor
City, University of London
Condition
Schizophrenia
RecruitingNCT06123897

Establishing a Clinical Database and Biobank for Schizophrenia:A Cohort Study

This study exists to understand how a digital app or remote support tool holds up over time after the earliest research stage. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOther
Countries
China
Sponsor
Central South University
Condition
Schizophrenia
Not Yet RecruitingNCT06700967

Evaluating Pharmacogenomics-Based Pharmacotherapy in Real-World Settings for Schizophrenia

This study exists to learn from real-world information that can show how a therapy or guided support program fits into care. Researchers are trying to understand how people respond to a therapy or guided support program in practice and what may need to be adjusted.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
China
Sponsor
Shanghai Mental Health Center
Condition
Schizophrenia
RecruitingNCT06341517

Brain Circuitry Therapeutics for Schizophrenia

This study exists to explore whether brain scans or other body measurements could improve care and understanding. Researchers are trying to understand whether brain scans or other body measurements can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Switzerland
Sponsor
Indrit Begue
Condition
Schizophrenia
Enrolling By InvitationNCT04323566

Rituximab Treatment for Psychosis And/or Obsessive Compulsive Disorder with Probable Immune System Involvement

This study exists to understand what helps a digital app or remote support tool work in everyday practice, not just under ideal conditions. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
Sweden
Sponsor
Uppsala University Hospital
Condition
Schizophrenia
CompletedNCT04902066

Face Your Fears: Cognitive Behavioural Virtual Reality Therapy for "Paranoia".

This study exists to compare options and see whether cognitive behavioural therapy, a structured talking treatment, offers something meaningfully different. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherOver 18 Years
Countries
Denmark
Sponsor
Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital
Condition
Schizophrenia
CompletedNCT06407154

Chronical Illness-related Limitations of the Ability to Cope with Rising Temperatures: an Observational Study, 2nd Wave

This study exists to learn from real-world information that can show how a digital app or remote support tool fits into care. Researchers are trying to understand whether a digital app or remote support tool can make support easier to access outside standard clinic visits.

DepressionOtherOver 18 Years
Countries
Germany
Sponsor
Universitätsklinikum Hamburg-Eppendorf
Condition
Depression
RecruitingNCT05457140

Multiomic Diagnostics in Youth With Psychosis

This study exists to see whether this type of care can make care clearer and more responsive. Researchers are trying to understand whether this type of care can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 7 Years to 17 Years
Countries
United States
Sponsor
Rady Pediatric Genomics & Systems Medicine Institute
Condition
Schizophrenia
CompletedNCT05670197

Service User and Staff Views on Digital Remote Monitoring for Psychosis

This study exists to understand how a digital app or remote support tool holds up over time after the earliest research stage. Researchers are trying to understand whether a digital app or remote support tool can better prevent setbacks and support longer-term stability.

SchizophreniaOtherOver 16 Years
Countries
United Kingdom
Sponsor
Manchester Academic Health Science Centre
Condition
Schizophrenia
CompletedNCT03557931

A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic Medication

This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
United States
Sponsor
Astellas Pharma Global Development, Inc.
Condition
Schizophrenia
CompletedNCT05105542

M1 Schizophrenia PET Study

This study exists to explore whether blood tests and biological markers could improve care and understanding. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Yale University
Condition
Schizophrenia
Not Yet RecruitingNCT06651112

The ATP Project (Antipsychotic-TEP-Psychosis)

This study exists to understand what helps brain scans or other body measurements work in everyday practice, not just under ideal conditions. Researchers are trying to understand whether brain scans or other body measurements can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 35 Years
Countries
Canada
Sponsor
Université de Sherbrooke
Condition
Schizophrenia
CompletedNCT03621774

Mobile CBT for Negative Symptoms

This study exists to compare options and see whether cognitive behavioural therapy, a structured talking treatment, offers something meaningfully different. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
United States
Sponsor
University of California, San Diego
Condition
Schizophrenia
CompletedNCT03179696

Mobile-Assisted Cognitive Behavior Therapy for Negative Symptoms in Schizophrenia

This study exists to explore whether cognitive behavioural therapy, a structured talking treatment, could improve care and understanding. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Global
Sponsor
Eric Granholm
Condition
Schizophrenia
CompletedNCT04959032

Lumateperone for the Prevention of Relapse in Patients With Schizophrenia

This study exists to compare options and see whether a medication treatment offers something meaningfully different. Researchers are trying to understand whether a medication treatment can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
Bulgaria, Poland, Serbia, United States
Sponsor
Intra-Cellular Therapies, Inc.
Condition
Schizophrenia
CompletedNCT02720263

A Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP4345 in Patients With Schizophrenia

This study exists to better understand the safety of a medication treatment and how manageable it feels in practice. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
United States
Sponsor
Astellas Pharma Global Development, Inc.
Condition
Schizophrenia